本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

10.14
+0.14001.40%
盤後10.10-0.0400-0.39%19:06 EDT
成交量:17.46萬
成交額:176.17萬
市值:1.80億
市盈率:-1.72
高:10.27
開:9.97
低:9.93
收:10.00
52周最高:20.56
52周最低:5.75
股本:1,773.65萬
流通股本:1,274.79萬
量比:0.83
換手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):-5.9000
每股收益(LYR):-5.9000
淨資產收益率:-54.18%
總資產收益率:-32.91%
市淨率:1.22
市盈率(LYR):-1.72

資料載入中...

2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/20

重要事件披露

Form 8-K - Current report
2024/03/20

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/18

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/02

重要事件披露

Form 8-K/A - Current report: [Amend]